Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 20249 | Other Identifier | Indiana University Institutional Review Board | |
| U54AG063546 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Aging (NIA) | NIH |
| Regenstrief Institute, Inc. | OTHER |
| Indiana University Health | OTHER |
Not provided
Not provided
Not provided
Not provided
The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Care Partners in the intervention group will be approached and offered care coordination through the Aging Brain Care Virtual program |
|
| Control | No Intervention | Care partners in the control group will not be approached, but outcomes data will be collected from the EMR for comparison with the intervention group. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aging Brain Care Virtual Program | Behavioral | The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning. |
| Measure | Description | Time Frame |
|---|---|---|
| Emergency Department Utilization | Total count of emergency department encounters per patient | During the 12 months of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| New prescriptions for antipsychotic medications | Total count of new prescriptions for antipsychotic medications | During the 12 months of intervention |
| New prescriptions for benzodiazepine medications |
Not provided
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Care Partners Inclusion Criteria:
Care Partners Exclusion Criteria:
- Individuals who decline to participate in the ABCV intervention
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alexia M Torke, MD, MS | Regenstrief Institute, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Regenstrief Institute, Inc. | Indianapolis | Indiana | 46202 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40987722 | Derived | Sauerteig-Rolston MR, Fowler NR, Sachs GA, Boustani M, Slaven J, Monahan PO, Burke ES, Higbie A, Torke AM. Pragmatic trial of a virtual dementia collaborative care management program: protocol for the Aging Brain Care Virtual (ABCV) program. BMJ Open. 2025 Sep 23;15(9):e108800. doi: 10.1136/bmjopen-2025-108800. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 21, 2026 | |
| Reset | Jun 17, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 21, 2026 | Jun 17, 2026 |
| ID | Term |
|---|---|
| D003704 | Dementia |
| D000544 | Alzheimer Disease |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D019965 | Neurocognitive Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
Total count of new prescriptions for benzodiazepine medications
| During the 12 months of intervention |
| Anticholinergic Cognitive Burden Scale score | Total score rating the anticholinergic burden of medications the patient is taking There are 88 medications on the Anticholinergic Cognitive Burden Scale. Possible anticholinergics include those listed with a score of 1; Definite anticholinergics include those listed with a score of 2 or 3. The overall ACB score is calculated by adding the score for each possible or definite anticholinergic medication that the patient is taking. An ACB Scale score can be as low as 0. The vast majority of patients have an ACB score at or below 4. Scores of 1 are low, 2 are moderate and anything above 3 is considered high. There is no published max score on the ACB scale, however, scores above 4 are somewhat uncommon. The top score could be as high as 264 (88x3) A higher ACB score indicates higher cognitive burden. Higher scores indicate worse outcomes. | Before and 12 months after initial intervention |
| Acceptability of the intervention score | Acceptability of Intervention Measure (AIM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality. | During the 12 month intervention period |
| Feasibility of the intervention score | Feasibility of Intervention Measure (FIM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality. | During the 12 month intervention period |
| Appropriateness of the intervention score | Intervention Appropriateness Measure (IAM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality. | During the 12 month intervention period |
| D001523 | Mental Disorders |
| D024801 | Tauopathies |
| D019636 | Neurodegenerative Diseases |